Animas Corporation
has announced Food and Drug
Administration (FDA)
approval of the Animas Vibe insulin pump and Continuous Glucose Monitoring
(CGM) system for the management of insulin-requiring diabetes in adults ages 18
and older.
As the first and only integrated system featuring Dexcom G4
PLATINUM sensing technology with proven accuracy, Animas Vibe allows patients
to view glucose data and administer insulin right from the pump; simplifying
and aiding their ability to make more informed decisions to fine tune insulin
delivery and manage their diabetes.
Diabetes
A comprehensive article on diabetes - both Type 1 and Type 2 diabetes, including : causes, signs, symptoms, diagnosis, treatment, facts and a glossary on diabetes.
Advertisement
The Animas Vibe system provides patients with their latest glucose readings on the pump screen and a complete view of glucose highs, lows, and rates of change over time. This information complements fingerstick testing results and can be used to help guide immediate and long - term insulin delivery therapy adjustments.
CGM technology
measures glucose levels every five minutes and provides real - time glucose
values, as well as trend information. CGM has been shown to improve glycemic
control in adult patients 25 years and older via lower HbA1c levels, less
frequent hypoglycemia, and reduced glucose variability.
![Diabetes Type 2 and Its Link to Sugar-Sweetened Beverages]( "Diabetes Type 2 and Its Link to Sugar-Sweetened Beverages")
Sugar-sweetened beverages contribute to metabolic syndrome leading to higher risk for type-2 diabetes and cardiovascular disease.
"For many people who are insulin dependent, diabetes is a demanding disease that can require day- to-day and hour -by-hour management.
We are pleased to now offer people with diabetes in the U.S. a solution with CGM technology that provides the ability to make more informed decisions to manage their disease, which can ultimately improve blood glucose control," said Dr. Brian Levy, Chief Medical Officer, Animas Corporation.
Animas Vibe also offers precise insulin dosing with a low basal increment of 0.025 U/hr across all available ranges (0.025 U/hr to 25.00 U/hr) and a low bolus increment of 0.05 U across all available bolus ranges (0.05 U to 35.00 U). Animas Vibe users can also personalize dosing by choosing individual insulin - to-carb ratios, insulin sensitivity factors, and blood glucose targets in 30-minute increments with up to 12 personal settings.
Source: Medindia
Diabetes Type 2 and Its Link to Sugar-Sweetened Beverages
Sugar-sweetened beverages contribute to metabolic syndrome leading to higher risk for type-2 diabetes and cardiovascular disease.
Advertisement
"For many people who are insulin dependent, diabetes is a demanding disease that can require day- to-day and hour -by-hour management.
We are pleased to now offer people with diabetes in the U.S. a solution with CGM technology that provides the ability to make more informed decisions to manage their disease, which can ultimately improve blood glucose control," said Dr. Brian Levy, Chief Medical Officer, Animas Corporation.
Animas Vibe also offers precise insulin dosing with a low basal increment of 0.025 U/hr across all available ranges (0.025 U/hr to 25.00 U/hr) and a low bolus increment of 0.05 U across all available bolus ranges (0.05 U to 35.00 U). Animas Vibe users can also personalize dosing by choosing individual insulin - to-carb ratios, insulin sensitivity factors, and blood glucose targets in 30-minute increments with up to 12 personal settings.
Source: Medindia
Diabetic Diet
The diabetic diet most often recommended is high in dietary fiber (especially soluble fiber) and nutrients, but low in fat (especially saturated fat) and moderate in calories.
Advertisement
 Gestational diabetesThe condition is not caused by a lack of insulin, but by the action of hormones produced during pregnancy that blocks the action of insulin. | Advertisement
|
Advertisement
Recommended Reading
Latest Medical Gadgets
A new dialysis device developed by researchers to treat individuals with severe liver failure is safe and effective.
The magnetically controlled capsule endoscopy shows promising results in treating issues related to stomach.
Scientists have developed an affordable, user-friendly clip that utilizes a smartphone's camera and flash to measure blood pressure at the user's fingertip.
Recent progress in the development of wearable devices has presented alternative ways for sleep monitoring at home, which could be useful in sleep apnea detection.
Researchers develop non-invasive brain imaging techniques to help people with disabilities.